A novel and essential mechanism determining specificity and activity of protein phosphatase 2A (PP2A) in vivo. 2003

Thomas Fellner, and Daniel H Lackner, and Hans Hombauer, and Patrick Piribauer, and Ingrid Mudrak, and Katrin Zaragoza, and Claudia Juno, and Egon Ogris
Institute of Medical Biochemistry, Division of Molecular Biology, Vienna Biocenter, University of Vienna, A-1030 Vienna, Austria.

Protein phosphatase 2A (PP2A) is an essential intracellular serine/threonine phosphatase containing a catalytic subunit that possesses the potential to dephosphorylate promiscuously tyrosine-phosphorylated substrates in vitro. How PP2A acquires its intracellular specificity and activity for serine/threonine-phosphorylated substrates is unknown. Here we report a novel and phylogenetically conserved mechanism to generate active phospho-serine/threonine-specific PP2A in vivo. Phosphotyrosyl phosphatase activator (PTPA), a protein of so far unknown intracellular function, is required for the biogenesis of active and specific PP2A. Deletion of the yeast PTPA homologs generated a PP2A catalytic subunit with a conformation different from the wild-type enzyme, as indicated by its altered substrate specificity, reduced protein stability, and metal dependence. Complementation and RNA-interference experiments showed that PTPA fulfills an essential function conserved from yeast to man.

UI MeSH Term Description Entries
D008670 Metals Electropositive chemical elements characterized by ductility, malleability, luster, and conductance of heat and electricity. They can replace the hydrogen of an acid and form bases with hydroxyl radicals. (Grant & Hackh's Chemical Dictionary, 5th ed) Metal
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010749 Phosphoprotein Phosphatases A group of enzymes removing the SERINE- or THREONINE-bound phosphate groups from a wide range of phosphoproteins, including a number of enzymes which have been phosphorylated under the action of a kinase. (Enzyme Nomenclature, 1992) Phosphoprotein Phosphatase,Phosphoprotein Phosphohydrolase,Protein Phosphatase,Protein Phosphatases,Casein Phosphatase,Ecto-Phosphoprotein Phosphatase,Nuclear Protein Phosphatase,Phosphohistone Phosphatase,Phosphoprotein Phosphatase-2C,Phosphoseryl-Protein Phosphatase,Protein Phosphatase C,Protein Phosphatase C-I,Protein Phosphatase C-II,Protein Phosphatase H-II,Protein-Serine-Threonine Phosphatase,Protein-Threonine Phosphatase,Serine-Threonine Phosphatase,Threonine Phosphatase,Ecto Phosphoprotein Phosphatase,Phosphatase C, Protein,Phosphatase C-I, Protein,Phosphatase C-II, Protein,Phosphatase H-II, Protein,Phosphatase, Casein,Phosphatase, Ecto-Phosphoprotein,Phosphatase, Nuclear Protein,Phosphatase, Phosphohistone,Phosphatase, Phosphoprotein,Phosphatase, Phosphoseryl-Protein,Phosphatase, Protein,Phosphatase, Protein-Serine-Threonine,Phosphatase, Protein-Threonine,Phosphatase, Serine-Threonine,Phosphatase, Threonine,Phosphatase-2C, Phosphoprotein,Phosphatases, Phosphoprotein,Phosphatases, Protein,Phosphohydrolase, Phosphoprotein,Phosphoprotein Phosphatase 2C,Phosphoseryl Protein Phosphatase,Protein Phosphatase C I,Protein Phosphatase C II,Protein Phosphatase H II,Protein Phosphatase, Nuclear,Protein Serine Threonine Phosphatase,Protein Threonine Phosphatase,Serine Threonine Phosphatase
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities
D016475 3T3 Cells Cell lines whose original growing procedure consisted being transferred (T) every 3 days and plated at 300,000 cells per plate (J Cell Biol 17:299-313, 1963). Lines have been developed using several different strains of mice. Tissues are usually fibroblasts derived from mouse embryos but other types and sources have been developed as well. The 3T3 lines are valuable in vitro host systems for oncogenic virus transformation studies, since 3T3 cells possess a high sensitivity to CONTACT INHIBITION. 3T3 Cell,Cell, 3T3,Cells, 3T3
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis

Related Publications

Thomas Fellner, and Daniel H Lackner, and Hans Hombauer, and Patrick Piribauer, and Ingrid Mudrak, and Katrin Zaragoza, and Claudia Juno, and Egon Ogris
March 2000, The Journal of biological chemistry,
Thomas Fellner, and Daniel H Lackner, and Hans Hombauer, and Patrick Piribauer, and Ingrid Mudrak, and Katrin Zaragoza, and Claudia Juno, and Egon Ogris
December 2014, Eukaryotic cell,
Thomas Fellner, and Daniel H Lackner, and Hans Hombauer, and Patrick Piribauer, and Ingrid Mudrak, and Katrin Zaragoza, and Claudia Juno, and Egon Ogris
June 2005, Eukaryotic cell,
Thomas Fellner, and Daniel H Lackner, and Hans Hombauer, and Patrick Piribauer, and Ingrid Mudrak, and Katrin Zaragoza, and Claudia Juno, and Egon Ogris
January 2007, Methods in molecular biology (Clifton, N.J.),
Thomas Fellner, and Daniel H Lackner, and Hans Hombauer, and Patrick Piribauer, and Ingrid Mudrak, and Katrin Zaragoza, and Claudia Juno, and Egon Ogris
November 2020, International journal of molecular sciences,
Thomas Fellner, and Daniel H Lackner, and Hans Hombauer, and Patrick Piribauer, and Ingrid Mudrak, and Katrin Zaragoza, and Claudia Juno, and Egon Ogris
May 2007, Molecular pharmacology,
Thomas Fellner, and Daniel H Lackner, and Hans Hombauer, and Patrick Piribauer, and Ingrid Mudrak, and Katrin Zaragoza, and Claudia Juno, and Egon Ogris
June 2008, Cancer metastasis reviews,
Thomas Fellner, and Daniel H Lackner, and Hans Hombauer, and Patrick Piribauer, and Ingrid Mudrak, and Katrin Zaragoza, and Claudia Juno, and Egon Ogris
December 2016, Journal of molecular and cellular cardiology,
Thomas Fellner, and Daniel H Lackner, and Hans Hombauer, and Patrick Piribauer, and Ingrid Mudrak, and Katrin Zaragoza, and Claudia Juno, and Egon Ogris
May 2007, Archives of biochemistry and biophysics,
Thomas Fellner, and Daniel H Lackner, and Hans Hombauer, and Patrick Piribauer, and Ingrid Mudrak, and Katrin Zaragoza, and Claudia Juno, and Egon Ogris
November 1999, The Plant journal : for cell and molecular biology,
Copied contents to your clipboard!